Metagenomi (MGX) Enterprise Value (2023 - 2025)
Metagenomi (MGX) has disclosed Enterprise Value for 3 consecutive years, with -$160.8 million as the latest value for Q4 2025.
- On a quarterly basis, Enterprise Value rose 35.24% to -$160.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$160.8 million, a 35.24% increase, with the full-year FY2025 number at -$160.8 million, up 35.24% from a year prior.
- Enterprise Value was -$160.8 million for Q4 2025 at Metagenomi, up from -$184.1 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$51.6 million in Q2 2023 to a low of -$327.4 million in Q1 2024.
- A 3-year average of -$203.9 million and a median of -$215.5 million in 2025 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: tumbled 480.7% in 2024, then surged 35.24% in 2025.
- Metagenomi's Enterprise Value stood at -$271.2 million in 2023, then rose by 8.44% to -$248.3 million in 2024, then soared by 35.24% to -$160.8 million in 2025.
- Per Business Quant, the three most recent readings for MGX's Enterprise Value are -$160.8 million (Q4 2025), -$184.1 million (Q3 2025), and -$205.0 million (Q2 2025).